We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





MedLab Middle East Continues as World's Largest Attended Laboratory Exhibition and Conference

By LabMedica International staff writers
Posted on 05 Feb 2018
MEDLAB Middle East, held a week after Arab Health, continued to be the largest attended laboratory and IVD exhibition and conference in the world. More...
Held from February 5-8, 2018, the annual laboratory meeting saw its second year as a stand-alone show and welcomed over 600 exhibitors and more than 25,000 attendees from 129+ countries.
 
MEDLAB is the flagship exhibition and congress of the MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US. As the largest attended laboratory expo worldwide, MEDLAB stems from 15 years of growth alongside the MENA region's largest healthcare gathering, Arab Health.
 
MEDLAB Middle East held in Dubai, UAE, continued to expand in 2018 with the addition of two new halls and the capacity to showcase thousands of new products, equipment and services by the main players in the industry. Leading laboratory experts, scientists, researchers and clinicians converged at the three-day event to exchange and share their experiences and research results on all aspects of laboratory medicine and clinical research while companies showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market.
 
At the heart of MEDLAB laboratory conference and exhibition lies the CME-accredited Congress featuring 17 CME-accredited conference tracks. Supported by the Cleveland Clinic, the MEDLAB conferences provide professionals with high-level CME credits. The MEDLAB Conferences cover a diverse range of subjects relating to laboratory management, microbiology, immunology, hematology, clinical chemistry and molecular diagnostics. With over 6,500 conference delegates in attendance from all over the world, the MEDLAB Congress is the ideal platform to come together and discover innovations in medical laboratory testing. MEDLAB Congress 2018 introduced new clinical tracks designed to enhance collaboration between laboratory professionals and clinicians. This will aid in accurate interpretation, quick reporting and diagnosis, therefore strengthening the laboratory’s ability to provide clinical decisions and improve the overall quality of service and care. 
 
This year’s MEDLAB Middle East also featured the Obs-Gyne Exhibition, which provided a platform for over 2,500 obstetricians, gynecologists, fertility specialists and family physicians to gather alongside 60+ of the industry's leading manufacturers to meet, exchange knowledge, share best practices and ultimately improve the level of patient care provided. Some of the key topics of discussion at the Obs-Gyne Exhibition were postpartum hemorrhage, androgen disorders in adolescents, psychological and sexual aspects in female genital cancer, early prediction and prevention of pre-eclampsia, obesity in pregnancy, treatment options for infertile women with uterine fibroids, and monitoring and delivery of the growth of restricted fetus.
 
The Poster Zone at the event displayed the latest research from laboratorians worldwide, promoting knowledge sharing and networking amongst MEDLAB’s delegates, who discussed the latest research, findings and developments within the industry. The Workshop Zone featured workshops hosted by leading laboratory and diagnostic companies who provided a hands-on approach towards utilizing the latest testing methods, findings and technology. MEDLAB Middle East also welcomed dealers and distributors from across the region as well as representatives from hospitals, consultancies and governments who took the opportunity to meet, do business with exhibitors and learn from all professionals within the healthcare and medical laboratory marketplace. 
 

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Automatic Hematology Analyzer
LABAS F9000
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.